Sodium Butyrate Supplementation Research Articles

Effect of Sodium Butyrate on Intestinal Health of Poultry – A Review

Abstract Health of the intestine is one of the main reasons that affects the bird’s performance, and thus the economic yield in the poultry sector. Various studies have examined how to improve the intestinal health using dietary supplements, including organic acids such as sodium butyrate (SB). The efficacy of the dietary supplementation in poultry is often assessed using an important parameter such as intestinal integrity, which is often assessed as a measure of high villus height and the ratio of villus height to crypt depth, or count of goblet cell numbers. In broilers, the villus length and width were increased by the addition of dietary SB. Since, at day 21 and 42, the villus length was increased by 55 and 27%, and 39 and 18% for birds fed 0.5 and 1 g/kg, respectively, compared with the control diet. Furthermore, SB plays an important role in development of poultry intestinal epithelium. It can be employed by the intestinal epithelial cells as an energy source to stimulate their differentiation and proliferation, and to improve intestinal barrier function. SB is effective against acid intolerant species such as Salmonella, Clostridium perfringens and E. coli. In addition, use of butyric acid at 0.6% reduced the pH of gastrointestinal segments. For this, SB could be a potential alternative in maintaining the health of gastrointestinal tract and improving the productive performance of poultry. This review refers to the expanding horizons in the research on SB supplementation in poultry health and nutrition.

Effects of laying breeder hens dietary β-carotene, curcumin, allicin, and sodium butyrate supplementation on the growth performance, immunity, and jejunum morphology of their offspring chicks

This study evaluated the growth performance, immunity, and jejunum morphology of chicks hatched from laying breeder hens given dietary additive supplementation, as well as chicks receiving direct antibiotic supplementation in early life. Hy-line breeder hens were allotted to 2 groups with 3 replicates. A control group (CON) was fed a basal diet, and the treatment group (CCAB) received β-carotene, curcumin, allicin, and sodium butyrate in addition to basal diet for 5 wk. Breeder–hen eggs were collected and hatched. The chicks hatched from the CON group were assigned to 2 treatments: a chick control group (cCON) and a chick treatment group (Cipro) given ciprofloxacin lactate into drinking water; the cCON group, Cipro group, and the chicks hatched from the CCAB group (cCCAB) were fed the same diet for 4 wk. The results demonstrated that there were significant differences between the CON and CCAB groups in the serum levels of IgA, IgG, IgM (triple P < 0.01), lysozyme (P < 0.05), and β-defensin (P < 0.05). The body weights of the cCCAB group's chicks increased at 1, 7, and 28 D of age (P < 0.05, P < 0.05, P < 0.01, respectively), and those of the Cipro group's chicks increased at 7 and 21 D of age (P < 0.01, P < 0.05). The tibial lengths of the cCCAB group's chicks increased at 1, 7, 14, 21, and 28 D of age (P < 0.01, P < 0.05, triple P < 0.01), and the lengths in the Cipro group increased at 7 and 14 D of age (P < 0.01, P < 0.01). Intestinal development, including intestinal length, jejunum morphology, and IgA positive cells, helps to explain these results. The breeder eggs from the CCAB group had higher IgG (P < 0.05) and IgM (P < 0.05) levels in the egg whites and higher IgA, IgG, and IgM levels (triple P < 0.01) in the egg yolks. In conclusion, β-carotene, curcumin, allicin, and sodium butyrate supplementation of laying breeder hen diets produced more advantages in growth performance and intestinal development in offspring than in chicks directly supplemented with antibiotics.

Effects of sodium butyrate on intestinal health and gut microbiota composition during intestinal inflammation progression in broilers

Butyric acid is a beneficial feed additive used in animal production, including poultry production. However, there are few reports on butyric acid as a prophylactic treatment against intestinal inflammation in broilers. The current study explored the effect of sodium butyrate (SB) as a prophylactic treatment on the intestinal health and gut microbiota of broilers with intestinal inflammation induced by dextran sulfate sodium (DSS) by monitoring changes in intestinal histopathology, gut leakiness indicators, inflammatory cytokines, and gut microbiota composition. Sodium butyrate supplementation prior to DSS administration significantly reduced the lesion scores of intestinal bleeding (P < 0.05) and increased villus height and the total mucosa of the ileum (P < 0.05). Regardless of intestinal inflammation, supplementation with SB at 300mg/kg significantly decreased the levels of D (-)-lactate (P < 0.05), interleukin-6, and interleukin-1β (P < 0.05) but increased the level of interleukin-10 (P < 0.05). The SB treatment did not affect the alpha diversity of intestinal microbiota during intestinal inflammation progression but altered their composition, and the microbial community structure of treated broilers was similar to that of control broilers. Taken together, our results reveal the importance of SB in improving intestinal development, inducing an anti-inflammatory effect during intestinal inflammation progression, and modulating the microbial community in broilers. Sodium butyrate seems to be optimized for anti-inflammatory effects at higher doses (300mg/kg SB).

Effects of dietary sodium butyrate on growth, diet conversion, body chemical compositions and distal intestinal health in yellow drum ( Nibea albiflora , Richardson)

The present study was conducted to investigate the effects of sodium butyrate (SB) on the physical barrier function, pro-inflammatory response and possible underlying mechanisms in the distal intestine (DI) of yellow drum when fed a high-SBM diet. Three iso-proteic and iso-lipidic diets were formulated with fish meal (FM, the control), 45% fish meal protein replaced by SBM (SBM) and 45% fish meal protein replaced by SBM but supplemented with 0.15% SB (SBM + SB). Fish were fed twice daily for 10 weeks. Results indicated that SB supplementation significantly increased the specific growth rate (SGR) and feed efficiency ratio (FER) and methionine content of muscle when compared with those of fish fed the SBM diet (p < .05). The morphologic histology results showed that SB dramatically improved the physical barrier structure, characterized as increases of fold height (FH) and muscular thickness (MT) (p < .05). RT-qPCR data were accordant with morphologic histology results, in which claudin 3, claudin 4 and occludin were increased while claudin 7 and myosin light chain kinase (MLCK) mRNA expression levels were decreased (p < .05). Sodium butyrate also exerted anti-inflammatory function, which may be attributed to the suppression of nucleus p65 protein expression. Results suggest SB can be incorporated in high-SBM diets to ameliorate the negative consequences of alternative dietary ingredients on yellow drum physiology.

Response of broiler chickens to xylanase and butyrate supplementation.

A 2 × 2 factorial experiment was used to evaluate the effect of xylanase and sodium butyrate supplementation on performance, intestinal fermentation, histology, and morphometry in broiler chickens. A total of 384 Ross 308 broiler chicks (1-day-old) were allocated to 4 experimental treatments: CTR (control diet), XYL (CTR diet with 16,000 BXU/kg of xylanase), BUT (CTR diet with 1kg/t sodium butyrate), and XYL+BUT (CTR diet plus xylanase and sodium butyrate). Each treatment had 8 replicates of 12 animals. Starter and grower diets, based on wheat and soybean meal, and water were available ad libitum. Body weight gain and feed intake were measured from 0 to 42 D, and feed conversion ratio corrected for mortality (FCR) was calculated. The profile of short-chain fatty acids in the duodenum, jejunum, ileum, and ceca digesta on days 21 and 42 was analyzed in addition to the relative weights of the different portions of the gastrointestinal tract (GIT). The villus height (VH), crypt depth (CD), and villus to crypt (VH: CD) ratio from the ileal tissue on day 42 were also evaluated. Statistical comparisons were performed using a 2-way ANOVA. Xylanase supplementation improved 42-D FCR by 5 points (P = 0.006), while butyrate did not affect 42-D FCR. On day 21, birds fed butyrate had heavier total GIT (P = 0.024), duodenum (P < 0.001), and jejunum (P = 0.025). Xylanase did not influence the relative weights in any intestinal section except the crop which was smaller in xylanase supplemented birds. At day 42, the VH: CD ratio was increased with sodium butyrate (P = 0.005). Supplementation of broiler diets with xylanase improved performance but had little effect on intestinal measures, whereas sodium butyrate influenced many of the intestinal indices with no consequence on animal performance.

Sodium Butyrate Modulates Mucosal Inflammation Injury Mediated by GPR41/43 in the Cecum of Goats Fed a High Concentration Diet.

Emerging data indicate that excessive short chain fatty acids can mediate the downstream mitogen-activated protein kinase pathways by activating G-protein coupled receptor 41/43 (GPR41/43) to initiate the inflammatory response. The current study was conducted to investigate if a high concentrate (HC) supplemented with sodium butyrate can alleviate the inflammation and if an epigenetic mechanism is involved in regulating the expression of the key GPR41/43 genes in the cecum. Twelve lactating goats were randomly divided into two groups: the control group fed the HC diet and the treatment group fed the HC diet supplemented with sodium butyrate (HCB). Our results suggested that the supplementation of sodium butyrate significantly increased the pH value in the rumen and cecum, downregulated the expression of GPR41/43 and related inflammatory cytokines, upregulated the expression of tight junction proteins, and reduced the protein expression levels of GPR 41/43, ERK1/2, and p38. Moreover, the ratios of DNA methylation and chromatin compaction in the promoter region of the GPR41/43 genes were altered due to the addition of sodium butyrate. In brief, dietary addition of sodium butyrate can reduce the inflammatory injury to the cecal mucosa in lactating goats and can affect the expression of GPR41/43 via epigenetic modification.

Stimulatory effect of dietary butyrate on growth, immune response, and resistance of Nile tilapia, Oreochromis niloticus against Aeromonas hydrophila infection

Acidifiers could be used as feed additives to stimulant performance, health, and immunity of fish fed plant-based diets. In the present study, sodium butyrate (SB) was incorporated in practical diets for Nile tilapia, Oreochromis niloticus (L.) to alleviate the adverse effects of high contents of plant ingredients in fish diets. However, Gustor BP-70 (Norel Misr), which is a protected SB (70%) coated with 30% of vegetable fat, was incorporated in a practical fish diet at levels of 0.0, 2.5, 5.0, 7.5, and 10.0 g/kg diet. Fish (5.4 ± 0.5 g) were fed the tested diets manually up to apparent satiation twice a day for 90 days in quadruplicates. At the end of the feeding trial, fish were intraperitoneally injected by pathogenic bacteria, Aeromonas hydrophila and kept under observation for 10 days to record any irregular clinical signs and daily fish mortality. Dietary SB showed stimulating-effects on fish growth, feed utilization, and innate immunity of Nile tilapia. Likewise, activities of serum lysozyme and respiratory burst as well as bactericidal and agglutination activities were significantly improved due to dietary SB supplementation in a dose-dependent trend. After A. hydrophila infection, no fish mortality was detected in fish fed 7.5–10.0 g SB/kg diet, whereas fish fed the control diet showed highest mortality (85.0%). Based on the regression curve, it could recommend the use of 6.25 g SB/kg diet as a feed supplement for Nile tilapia to enhance its performance, immunity, and resistance against the possible infection by pathogenic bacteria A. hydrophila.

Dietary sodium butyrate (Butirex® C4) supplementation modulates intestinal transcriptomic responses and augments disease resistance of rainbow trout (Oncorhynchus mykiss)

Intestine in fish is a complex multifunctional organ, not only plays roles in digestion and absorption of nutrient, but also has critical role in immunity. The present study evaluated the effects of different levels of dietary sodium butyrate [Butirex® C4 (Butirex)] on intestinal immune-,antioxidant-and tight junction-related gene expression injuvenile rainbow trout(Oncorhynchusmykiss). 240 healthy rainbow trout were dispensed in 12 fiberglass tanks appointed to four treatments [0 (control), 1.5 (B1.5), 2.5 (B2.5) and 5 (B5)g Butirex per kg diet]. After a 45-day feeding trial, the fish fed with the Butirex-supplemented diets showed higher intestinal lysozyme (LYZ), complement(ACH50) and bactericidal activities; the elevations in ACH50 and bactericidal activities depended on Butirex levels (P < 0.05). The Butirex-supplemented groups, particularly the B2.5 group, had significantly higher LYZ gene expression compared to the control group (P < 0.05). Butirex at 2.5 and 5 g/kg levels led to significantly higher IL-1β gene expression. B2.5 and B5 had significantly lower and higher TNF-α gene expression compared to the control group (P < 0.05). The B2.5 group had significantly higher TGF-B, and significantly lower IL-8 compared to the control group (P < 0.05). The B1.5 and B2.5 group had significantly higher IL-10 gene expression compared to the control group (P < 0.05). The B2.5 and B5 groups had significantly higher SOD gene expression compared to the other groups; the highest expression was related to the B2.5 group (P < 0.05). Dietary Butirex supplementation significantly up-regulated CAT and GPx genes expression compared to the control group; the highest expression as related to the B2.5 and B5 groups (P < 0.05). The B2.5 group had significantly lower CLD12 gene expression compared to the control group (P < 0.05). The B2.5 and B5 groups had significantly higher CLD3, OCLD and ZO-1 gene expression compared to the control. The highest CLD3, ZO-1 gene expressions was related to the B2.5, and B5 groups respectively (P < 0.05). After challenge with Streptococcus iniae, B2.5 and B5 had significantly higher survival compared to the control group (55.6 ± 7.70 and 68.9 ± 10.2 vs. 33.3 ± 6.67). In conclusion, Butirex is efficient immune stimulant and health booster in rainbow trout, which augments the fish resistance to disease. Modulation of immune components, cytokines, antioxidant system and intestinal integrity might involve in improving disease resistance in Butirex-treated fish. Although most of the examined genes were modulated by 2.5 g/kg Butirex under normal conditions, 5 g/kg level is recommended under pathogenic state to mitigate mortality.

Effect of benzoic acid, sodium butyrate and sodium butyrate coated with benzoic acid on growth performance, digestibility, intestinal morphology and meat quality in grower-finisher pigs

Organic acids and their salts have the potential to promote growth in weaner and grower-finisher pigs. The aim of this project was to evaluate the effects of benzoic acid, sodium butyrate and sodium butyrate coated with benzoic acid on the growth performance, total tract energy digestibility, gut morphology and meat quality in grower-finisher pigs between 30 and 90 kg live weight. Sixty-four Duroc x (Large White x Landrace) pigs were balanced for live weight within sex and allocated to 4 dietary treatment groups (8 males and 8 females per group): control diet (C), C + benzoic acid (4.95 g/kg diet), C + sodium butyrate (1.47 g/ kg diet) and C + sodium butyrate (0.9 g/kg diet) coated with benzoic acid (2.1 g/kg diet). There was no significant difference between sexes or between dietary treatments for the organic or energy digestibility or the histological measurements: mucosal depth, villi length, crypt depth, number of goblet cells in villi, and number of goblet cells in crypt. Male pigs had a higher daily feed intake (P<0.05) and higher average daily gain (P<0.05), a lower feed conversion ratio (P<0.05), were heavier at slaughter (P<0.05) and consequently had a higher carcass weight (P<0.05) than female pigs. The ultimate pH was higher for male pigs than female pigs. No statistically significant differences (P>0.05) were found between the diets for any of the growth performances or meat quality parameters. However, when butyrate was added to the diet, L* values (P = 0.052) and percentage (%) drip losses after 24 h tended to be higher (P = 0.053). The supplementation of benzoic acid, sodium butyrate or sodium butyrate coated with benzoic acid in the diet, had no significant effect on growth performance, meat quality, digestibility or gut morphology in grower-finisher pigs kept under nutritional and environmental low-stress conditions.

Indole-3-carbinol prevents murine colitis development via an IL-22-dependent mechanism that regulates anti-microbial peptides and mucus production

Abstract Colitis is an inflammatory bowel disease characterized by acute or chronic inflammation within the colon. In our previous work, we showed that indole-3-carbinol (I3C), a naturally-occurring plant product found in a number of cruciferous vegetables, was able to prevent development of colitis in murine models. I3C prevented colitis-associated microbial dysbiosis characterized by an overabundance of potentially pathogenic gram-negative bacteria (e.g. Bacteroides acidifaciens), in addition to increasing anti-inflammatory gram-positive butyrate-producing species (e.g. Roseburia). This increase in butyrate by I3C, validated by metabolomics analysis, leads to a decrease in the pro-inflammatory T cell response (Th17) and an increase in anti-inflammatory Tregs, which was confirmed by sodium butyrate supplementation experiments. In the current study, we further defined the mechanisms by which I3C was able to prevent colitis-associated microbial dysbiosis and dysregulation of gut microbial metabolome by evaluating expression of key intestinal regulatory genes in immune cells and colonic epithelial cells (CECs). Transcriptome analysis and PCR validation of CECs showed mucus production (e.g. Muc2) and colonic anti-microbial peptides (e.g. beta-defensins) were significantly increased after I3C. I3C was also shown to, in a butyrate-independent manner, increase expression of colonic bacterial defensive interleukin-22 (IL-22) by epigenetic regulation. Lastly, in vivo IL-22 neutralization experiments negated the beneficial effects of I3C, thus proving this cytokine was crucial in I3C-mediated prevention of colitis development and regulation of key intestinal regulatory components such as mucus and AMP production.

Effect of Sodium Butyrate Supplementation on the Gut Microbiome during Colorectal Cancer

Abstract Colorectal Cancer(CRC) is most common cancer of gastrointestinal tract. In the current study, we investigated the effects of sodium butyrate (BUT) on azoxymethane-dextran sodium sulfate (AOM-DSS)-induced CRC murine model. The data shows that supplementation with BUT reduces overall CRC severity. Endoscopic and histopathological evaluation showed BUT decreased colonic tissue damage and tumor growth. In addition, BUT was able to decrease myeloid-derived suppressor cells (MDSCs) in the blood and BUT was able to altered T cells populations which included significant increases in Tregs and IL-10 producing T cells while decreasing Th1 and Th17 cells. To investigate alterations in the gut microbiome we performed 16S rRNA sequencing of cecal flushes and validated significant findings. The data showed AOM-DSS administration led to significant decreases in bacterial species Ruminococcus gnavus and Akkermansia muciniphila, however, mice that were treated with BUT showed a reversal in these gut microbial alterations. We quantified short chain fatty acids (SCFA). AOM-DSS administration led to a significant decrease in i-butyric and n-butyric acids, but mice supplemented with BUT restored these SCFA levels significantly. Lastly, we examined in vivo and in vitro expression of histone deacetylases (HDACs) after supplementing BUT. Results showed that BUT was able to decrease Class I (HDAC I) and class II (HDACII) in both in vivo and in vitro studies which correlated with a significant increase in Tregs. Collectively, these data showed that BUT can ameliorate CRC by preventing cancer-associated gut microbial dysbiosis through increase in i-butyric and n-butyric acids level which leads to an anti-inflammatory response by suppressing HDACs.

Sodium butyrate supplementation in high-soybean meal diets for turbot (Scophthalmus maximus L.): Effects on inflammatory status, mucosal barriers and microbiota in the intestine

A 12-week feeding trial was conducted to evaluate the effects of dietary sodium butyrate (NaBT) on the intestinal health of juvenile turbot (Scophthalmus maximus L.), in terms of inflammatory status, mucosal barriers and microbiota. Three isonitrogenous and isolipidic practical diets were used: (1) fish meal based group (FM); (2) soybean meal group (SBM), soy protein replacing 40% fish meal protein in FM; (3) NaBT group, 0.2% NaBT supplemented in SBM. Each diet was fed to triplicate tanks (30 fish in each tank). The current results showed that 0.2% dietary NaBT improved the growth performance of fish and alleviated the enteropathy, increasing the absorptive surface and mitigating the infiltration of mixed leukocytes in lamina propria. Fish fed the NaBT diet presented increased activities of intestinal brush border enzyme and similar nutrient digestibility with the FM group. Compared to SBM, the inclusion of 0.2% NaBT in diet significantly up-regulated the intestinal gene expression of tight junction proteins and down-regulated the gene expression of TNF-α and NF-κB. The gut microbial communities of the NaBT group were closer to the FM group than to the SBM group, in terms of PCoA, UPGMA and Heatmap analyses based on weighted Unifrac distance. The relative abundance of several dominant bacteria at the phylum (Proteobacteria, Bacteroidetes, Deinococcus-Thermus and Actinobacteria) and genus level (Thermus, Acinetobacter, Bacteroides and Silanimonas) were altered by dietary NaBT. In conclusion, dietary NaBT had positive roles in protecting the intestinal health of turbot from the impairment of soybean meal.

Supplementation of sodium butyrate to postweaned heifer diets: Effects on growth performance, nutrient digestibility, and health

The objective of this study was to determine the effect of varying levels of sodium butyrate (SB) supplementation in feed on the growth, digestibility, and health of postweaned heifers. Forty Holstein dairy heifers with a mean age of 84 d and average body weight (BW) of 100.9 ± 11.2 kg were housed in a naturally ventilated freestall barn. Heifers were blocked by birth date and randomly assigned to 1 of 4 treatments in a completely randomized block design: (1) 100 g of soybean meal carrier (control), (2) 0.25 g of SB/kg of BW plus carrier, (3) 0.50 g of SB/kg of BW plus carrier, and (4) 0.75 g of SB/kg of BW plus carrier. Carrier with or without SB was top-dressed and hand-mixed into a total mixed ration once daily. Heifers were fed to provide 10% orts. Initial BW, hip and withers heights, heart girth, and body length were measured before the start of the study and every week thereafter until the 14-wk trial was over. Blood samples were obtained and plasma urea nitrogen, plasma glucose, and whole-blood β-hydroxybutyrate concentrations were determined before the start of treatment and weekly thereafter until the conclusion of the study. Fecal samples were taken before treatment and every other week from each heifer for coccidia counts. Apparent total-tract nutrient digestibility was determined using acid detergent insoluble ash as an internal marker. Each heifer underwent this phase from d 47 until d 54 of the study. Sodium butyrate had a positive effect on average BW and overall BW gain. Feed efficiency tended to improve as SB supplementation increased. Coccidia counts were lowest in the treatment with 0.25 g of SB/kg of BW plus carrier. Sodium butyrate had no effects on skeletal growth or plasma urea nitrogen concentration. Blood glucose concentration decreased linearly and β-hydroxybutyrate increased linearly with increasing levels of SB supplementation. Sodium butyrate supplementation did not affect apparent total-tract nutrient digestibility. Sodium butyrate supplementation offers positive results in the growth performance and feed efficiency of postweaned heifers.

Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males

Sodium butyrate is well-known for its immune-modulatory properties. Studies until now only focused on the in vitro effects of butyrate or assessed local effects in the gut upon butyrate administration. In this trial, we studied the systemic anti-inflammatory effects induced by sodium butyrate supplementation in humans. Nine healthy (Lean) and ten obese (metabolic syndrome group, MetSyn) males were given 4 grams sodium butyrate daily for 4 weeks. PBMCs were isolated before and after supplementation for direct stimulation experiments and induction of trained immunity by oxidized low-density lipoprotein (oxLDL), β-glucan, or Bacillus Calmette-Guérin vaccine (BCG). Butyrate supplementation moderately affected some of the cytokine responses in the MetSyn group. In the direct stimulation setup, effects of butyrate supplementation were limited. Interestingly, butyrate supplementation decreased oxLDL-induced trained immunity in the MetSyn group for LPS-induced IL-6 responses and Pam3CSK4-induced TNF-α responses. Induction of trained immunity by β-glucan was decreased by butyrate in the MetSyn group for Pam3CSK4-induced IL-10 production. In this study, while having only limited effects on the direct stimulation of cytokine production, butyrate supplementation significantly affected trained immunity in monocytes of obese individuals with metabolic complications. Therefore, oral butyrate supplementation may be beneficial in reducing the overall inflammatory status of circulating monocytes in patients with metabolic syndrome.

Effect of dietary sodium butyrate supplementation on growth, blood biochemistry, haematology and histomorphometry of intestine and immune organs of Japanese quail

New strategies must be developed to improve poultry performance and health. One of these strategies is the use of supplementations as sodium butyrate (SB) to improve the physiological status and then increasing the growth performance, but the best period of age in which the addition of SB is more effective on birds is not well understood. Therefore, the aim of this study was to investigate the effect of dietary inclusion of SB supplementation through the first, second or whole growth period on some physiological indices and growth performance of growing Japanese quail. In total, 240 unsexed 1-day-old quail chicks were divided into four groups (three replicates per group of 20 chicks in each). The first group was fed basal diet without SB from 1 to 42 days (control, T1), while SB at a rate of 1 g/kg basal diet was mixed with the feed of the 2nd, 3rd and 4th groups of chicks from 1 to 21 days (SB 1 to 21, T2), 1 to 42 days (SB 1 to 42, T3) and 22 to 42 days (SB 22 to 42, T4) of age, respectively. The results stated that addition of SB significantly improved live BW at 21 days, feed conversion ratio (FCR) and BW gain (BWG) during 1 to 21 days in T2 and T3 groups compared to T1 and T4 groups. During the whole period, group T3 had higher BWG and better FCR than the other groups (T1, T2 and T4). At 21 days, no significant differences among all treatments were detected on haematology and serum biochemistry except total protein and cholesterol. At 42 days, SB supplementation significantly improved most serum constituents, haematological parameters, villus height and width of intestine and morphometry of immune organs. The group fed SB throughout the experiment (T3) showed the best results. In conclusion, it is recommended feeding quail on diets containing SB through the whole growth period to show its affirmative impact on the growth and physiological indices.

Effect of supplementation of nicotinamide and sodium butyrate on the growth performance, liver mitochondrial function and gut microbiota of broilers at high stocking density.

This study was conducted to investigate the effects of stocking density and dietary nicotinamide (NAM) and butyrate sodium (BA) supplementation on the growth performance, liver mitochondrial function and gut microbiota of broilers at high stocking density. A total of 342, 26-d-old Cobb500 broilers were divided into 5 groups with 6 replicates. Treatments were as follows: (a) Low stocking density (L, 9 birds per cage); (b) High stocking density (H, 12 birds per cage); (c) H + 50 ppm NAM; (d) H + 500 ppm BA; (e) H + 50 ppm NAM + 500 ppm BA (COMB). The results showed that high stocking density significantly reduced the feed intake and body weight gain of broilers, while COMB improved the growth performance at high stocking density. High stocking density significantly reduced the liver metallothionein content, liver mitochondrial membrane potential and the activities of Na+K+-ATPase and Ca2+Mg2+-ATPase. In contrast, the liver metallothionein contents in the NAM, BA and COMB fed group were higher than those in the H group. COMB increased the activity of ATPase as well, but it failed to enhance the mitochondrial membrane potential. Stocking density also affected gut microbiota of broilers. The high-density group increased the relative abundance of Blautia. Supplementation of BA and NAM increased the abundance of Lactobacillus and Bifidobacteria, respectively. In conclusion, a combination of NAM and BA can improve the performance, antioxidant capacity, mitochondrial function and intestinal microbiota of broilers at high stocking density.

Supplementation of Protected Sodium Butyrate Alone or in Combination With Essential Oils Modulated the Cecal Microbiota of Broiler Chickens Challenged With Coccidia and Clostridium perfringens

The objective of this study was to determine the effects of protected sodium butyrate (SB), and protected sodium butyrate plus essential oils (carvacrol and ginger; SBEO) on the cecal microbiota of broilers challenged with Eimeria maxima and Clostridium perfringens. Birds were assigned to 4 treatments (8 replicates pens of 58 birds/pen): unchallenged control; challenged control; challenged and supplemented with SB; challenged and supplemented with SBEO. On d 13, challenged birds were orally inoculated with ~5,000 Eimeria maxima oocysts. On d 18-19, the same birds were exposed to Clostridium perfringens via drinking water (~ 8 log CFU/ml). Cecal excreta was collected at d 12, 18, 21, and 28 for microbiome analysis through 16s rRNA sequencing using Illumina MiSeq platform and analyzed using QIIME v. 1.9.1 The cecal microbiota was analyzed over time within each experimental group. The inclusion of SB alone or in combination with EO contributed to larger variations in the cecal microbiota over time than the unsupplemented treatments, as shown by the diversity indices. The community structure and abundance of the cecal microbiota were significantly different across ages, especially in the groups supplemented with SB and SBEO. As shown in the PCoA analysis, the supplementation of SB led to a more stable microbial community and lower between-sample variability over time. In the unchallenged control birds, Ruminococcus decreased (p = 0.006), whereas Bacteroides and Clostridiales increased (p ≤ 0.02) as the birds aged. In the challenged control group, however, the frequency of Coprococcus and Blautia decreased as birds aged (p ≤ 0.01), and, Clostridiales did not increase. Supplementation of SB, but not SBEO, increased the frequency of Lactobacillus (p = 0.01) on d 12 compared to d 18 and d 28, and prevented the reduction in the frequency of Blautia as the birds aged. Nevertheless, supplementation of SB and SBEO contributed to unique changes in the predicted functions of the cecal microbiota over time, which was not observed in the unsupplemented birds. SB and SBEO modulated the diversity, composition, and predictive function of the cecal microbiota which may have lowered the negative impact of necrotic enteritis (NE).

Butyrate Protects Mice Against Methionine-Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels.

Butyrate exerts protective effects against non-alcoholic steatohepatitis (NASH), but the underlying mechanisms are unclear. We aimed to investigate the role of butyrate-induced gut microbiota and metabolism in NASH development. Sixty-five C57BL/6J mice were divided into four groups (n = 15–17 per group) and were fed either a methionine–choline-sufficient (MCS) diet or methionine–choline-deficient (MCD) diet with or without sodium butyrate (SoB; 0.6 g/kg body weight) supplementation for 6 weeks. Liver injury, systematic inflammation, and gut barrier function were determined. Fecal microbiome and metabolome were analyzed using 16S rRNA deep sequencing and gas chromatography-mass spectrometry (GC-MS). The results showed that butyrate alleviated the MCD diet-induced microbiome dysbiosis, as evidenced by a significantly clustered configuration separate from that of the MCD group and by the depletion of Bilophila and Rikenellaceae and enrichment of promising probiotic genera Akkermansia, Roseburia, Coprococcus, Coprobacillus, Delftia, Sutterella, and Coriobacteriaceae genera. The fecal metabolomic profile was also substantially improved by butyrate; several butyrate-responsive metabolites involved in lipid metabolism and other pathways, such as stearic acid, behenic acid, oleic acid, linoleic acid, squalene, and arachidonic acid, were identified. Correlation analysis of the interaction matrix indicated that the modified gut microbiota and fecal metabolites induced by butyrate were strongly correlated with the alleviation of hepatic injury, fibrosis progression, inflammation, and lipid metabolism and intestinal barrier dysfunction. In conclusion, our results demonstrated that butyrate exerts protective effects against NASH development, and these effects may be driven by the protective gut microbiome and metabolome induced by butyrate. This study thus provides new insights into NASH prevention.

The suppression of TXNIP and miR-200c improve beta-cell function in patients with Type 2 diabetes: A randomized, double-blind, placebo-controlled trial

The past decade has witnessed for high prevalence of various metabolic, lifestyle, and diet-related maladies such as diabetes. Currently, one of the new treatment methods and approaches for controlling chronic degenerative diseases such as diabetes is dissecting the disease’s molecular mechanisms. The aim of this study was to evaluate the beneficial effects of sodium butyrate and inulin supplementation on the beta-cell function and inflammatory responses through molecule-based mechanisms in patients with Type 2 diabetes.In this clinical trial, 60 patients with Type 2 diabetes were recruited from the north-western part of Iran. The participants were allocated to one of the four treatment orders. Group A took six capsules of 100 mg of NaBut daily, group B took 10 g of HP inulin supplement powder daily, group C consumed both the supplements, and group D took placebo. Before and after the intervention, we assessed the thioredoxin-interacting protein (TXNIP), interleukin-6, and interleukin-10 mRNA expression, as well as noting the plasmatic levels of the miR-204, miR-200c, and miR-21. A homeostasis model assessment of beta-cells (HOMA-β) was used to evaluate the function of the pancreatic beta-cells. The results showed that TXNIP expression was over three times higher in the placebo group as compared to the butyrate + inulin group (p = 0.045). Furthermore, the plasmatic levels of miR-200c expression decreased in the groups A (butyrate) and C (butyrate + inulin) (p < 0.001), as opposed to its constant level in the placebo. Interestingly, IL-6 mRNA expression decreased after butyrate (p < 0.001) and butyrate + inulin supplementation (p < 0.001). Our results revealed new insights into how TXNIP functions have a role in controlling diabetes. The newly identified TXNIP-miR-200c-IL-6-beta-cell function pathway may contribute to diabetes progression. Inhibiting TXNIP and miR-200c activity may be a potential pharmacological target to promote beta-cell function.

Effects of dietary sodium butyrate on reproduction in adult breeder roosters

Sodium butyrate (SB) is a novel feed additive in poultry production. This study aimed to evaluate the effects of dietary supplementation of SB on the reproductive performance of the rooster. Three hundred 22-week-old roosters were randomly divided into 2 dietary treatment groups of 6 pen replicates, a basal diet (control) group and a basal diet with SB gruop. The supplementation of SB was carried out through 23 consecutive weeks from 22 to 45 weeks of age. During this period, the live-weight was measured weekly while semen samples were collected every two weeks. Three time-points were chosen for analysis (30, 35 and 45 weeks of age). The results showed that SB improved the semen volume and sperm motility at 30 and 35 weeks of age (P < 0.05), increased the sperm concentration and decreased the abnormal sperm percentage during the whole experimental period (P < 0.05). These improvements were accompanied by increased testosterone levels at 30 and 35 weeks of age (P < 0.05). Moreover, dietary supplementation of SB also increased the enzyme activities of glutathione peroxidase (GPx) at 30 and 35 weeks of age and superoxide dismutase (SOD) at 45 weeks of age in the testes of roosters (P < 0.05). These results suggest that SB may promote testicular growth by increasing the antioxidant capacity and testosterone hormone secretion in adult roosters.